CLARISSA MALAFRONTE: Open Payments
NPI 1972051241 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,727 in 107 payments from 17 companies in 2025. Trend: 2023 $2,574 · 2024 $3,140 · 2025 $3,727
Food & beverage: $3,655Education: $72
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $624 |
| Arcutis Biotherapeutics, Inc. | 5 | $436 |
| ABBVIE INC. | 12 | $410 |
| Galderma Laboratories, L.P. | 15 | $336 |
| PFIZER INC. | 13 | $305 |
| GENZYME CORPORATION | 4 | $302 |
| Botanix SB Inc | 9 | $235 |
| Janssen Biotech, Inc. | 2 | $217 |
| Lilly USA, LLC | 6 | $187 |
| Regeneron Healthcare Solutions, Inc. | 3 | $136 |
Products named: Bimzelx, Zoryve, DUPIXENT, NEMLUVIO, CIBINQO, SOFDRA, SKYRIZI, TREMFYA.
Industry payments across FL — which companies pay providers there.
